A new report claims discovery of an ECG biomarker for sudden cardiac death using deep learning. The item describes a computational approach that identifies a signal pattern from ECG data intended to correlate with risk of sudden cardiac death, positioning the method as a potential pathway to earlier detection. Because the provided content is limited to a submission-style post without full peer-reviewed details, the immediate industry takeaway is the signal of active experimentation in AI-driven cardiovascular risk stratification. For biotech and medtech stakeholders, the next validation steps are expected to include prospective cohort testing, external dataset reproducibility, and clinical utility endpoints. If validated, ECG biomarkers with AI inference could reshape how cardiology programs screen high-risk populations, potentially reducing reliance on more invasive workups.